BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baldin P, Van den Eynde M, Mlecnik B, Bindea G, Beniuga G, Carrasco J, Haicheur N, Marliot F, Lafontaine L, Fredriksen T, Lanthier N, Hubert C, Navez B, Huyghe N, Pagès F, Jouret-Mourin A, Galon J, Komuta M. Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore. J Pathol Clin Res 2021;7:27-41. [PMID: 32902189 DOI: 10.1002/cjp2.178] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang C, Wang X, Han J, Zhang R, Chen Z, Li Y, Ma X, Zhang G, Fan J, Chen J. Histological tumor response to neoadjuvant chemotherapy correlates to Immunoscore in colorectal cancer liver metastases patients. J Surg Oncol 2021;124:1431-41. [PMID: 34406653 DOI: 10.1002/jso.26651] [Reference Citation Analysis]
2 Park HE, Yoo SY, Cho NY, Bae JM, Han SW, Lee HS, Park KJ, Kim TY, Kang GH. Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX. Sci Rep 2021;11:14609. [PMID: 34272423 DOI: 10.1038/s41598-021-94044-4] [Reference Citation Analysis]
3 Randrian V, Desette A, Emambux S, Derangere V, Roussille P, Frouin E, Godet J, Karayan-Tapon L, Ghiringhelli F, Tougeron D. New Artificial Intelligence Score and Immune Infiltrates as Prognostic Factors in Colorectal Cancer With Brain Metastases. Front Immunol 2021;12:750407. [PMID: 34733283 DOI: 10.3389/fimmu.2021.750407] [Reference Citation Analysis]
4 Messaoudi N, Henault D, Stephen D, Cousineau I, Simoneau E, Rong Z, Létourneau R, Plasse M, Dagenais M, Roy A, Lapointe R, Vandenbroucke-Menu F, Kunda R, Ysebaert D, Soucy G, Stagg J, Vermeulen P, Turcotte S. Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns. Br J Cancer 2022. [PMID: 34980880 DOI: 10.1038/s41416-021-01667-5] [Reference Citation Analysis]
5 Penny SA, Abelin JG, Malaker SA, Myers PT, Saeed AZ, Steadman LG, Bai DL, Ward ST, Shabanowitz J, Hunt DF, Cobbold M. Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer. Front Immunol 2021;12:723566. [PMID: 34504498 DOI: 10.3389/fimmu.2021.723566] [Reference Citation Analysis]
6 Garcia-vicién G, Mezheyeuski A, Micke P, Ruiz N, Ruffinelli JC, Mils K, Bañuls M, Molina N, Losa F, Lladó L, Molleví DG. Spatial Immunology in Liver Metastases from Colorectal Carcinoma according to the Histologic Growth Pattern. Cancers 2022;14:689. [DOI: 10.3390/cancers14030689] [Reference Citation Analysis]
7 Rigamonti A, Feuerhake F, Donadon M, Locati M, Marchesi F. Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases. Cancers (Basel) 2021;13:1075. [PMID: 33802446 DOI: 10.3390/cancers13051075] [Reference Citation Analysis]
8 Baldin P, Van den Eynde M, Mlecnik B, Galon J. Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients. Oncoimmunology 2020;9:1826133. [PMID: 33110705 DOI: 10.1080/2162402X.2020.1826133] [Reference Citation Analysis]